vs
德康医疗(DXCM)与格罗方德(GFS)财务数据对比。点击上方公司名可切换其他公司
格罗方德的季度营收约是德康医疗的1.3倍($1.7B vs $1.3B),德康医疗净利率更高(21.2% vs 14.8%,领先6.5%),德康医疗同比增速更快(21.6% vs -2.9%),过去两年德康医疗的营收复合增速更高(12.0% vs -4.3%)
德康医疗是美国跨国医疗保健企业,专注于研发、生产及销售糖尿病管理领域的连续血糖监测(CGM)系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥,生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
格罗方德是跨国半导体代工及设计企业,注册地为开曼群岛,总部位于美国纽约州马耳他。公司2009年3月由AMD制造业务分拆成立,2021年10月完成首次公开募股,阿联酋主权财富基金穆巴达拉投资公司目前仍持有其82%的多数股权。
DXCM vs GFS — 直观对比
营收规模更大
GFS
是对方的1.3倍
$1.3B
营收增速更快
DXCM
高出24.5%
-2.9%
净利率更高
DXCM
高出6.5%
14.8%
两年增速更快
DXCM
近两年复合增速
-4.3%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $1.7B |
| 净利润 | $267.3M | $249.0M |
| 毛利率 | 62.9% | 24.8% |
| 营业利润率 | 25.6% | 11.6% |
| 净利率 | 21.2% | 14.8% |
| 营收同比 | 21.6% | -2.9% |
| 净利润同比 | 153.6% | 39.9% |
| 每股收益(稀释后) | $0.67 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DXCM
GFS
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.0B | $1.6B | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | $1.7B | ||
| Q2 24 | $1.0B | $1.6B |
净利润
DXCM
GFS
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $249.0M | ||
| Q2 25 | $179.8M | $228.0M | ||
| Q1 25 | $105.4M | $211.0M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $178.0M | ||
| Q2 24 | $143.5M | $155.0M |
毛利率
DXCM
GFS
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | 24.8% | ||
| Q2 25 | 59.5% | 24.2% | ||
| Q1 25 | 56.9% | 22.4% | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | 23.8% | ||
| Q2 24 | 62.4% | 24.2% |
营业利润率
DXCM
GFS
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | 11.6% | ||
| Q2 25 | 18.4% | 11.6% | ||
| Q1 25 | 12.9% | 9.5% | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | 10.6% | ||
| Q2 24 | 15.7% | 9.5% |
净利率
DXCM
GFS
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 14.8% | ||
| Q2 25 | 15.5% | 13.5% | ||
| Q1 25 | 10.2% | 13.3% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | 10.2% | ||
| Q2 24 | 14.3% | 9.5% |
每股收益(稀释后)
DXCM
GFS
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | $0.44 | ||
| Q2 25 | $0.45 | $0.41 | ||
| Q1 25 | $0.27 | $0.38 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | $0.32 | ||
| Q2 24 | $0.35 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $2.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $11.8B |
| 总资产 | $6.3B | $16.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DXCM
GFS
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | $2.0B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $904.9M | $1.6B | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | $2.3B | ||
| Q2 24 | $939.2M | $2.2B |
股东权益
DXCM
GFS
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $11.8B | ||
| Q2 25 | $2.6B | $11.5B | ||
| Q1 25 | $2.3B | $11.1B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | $11.6B | ||
| Q2 24 | $2.4B | $11.3B |
总资产
DXCM
GFS
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | $16.7B | ||
| Q2 25 | $7.3B | $16.8B | ||
| Q1 25 | $6.8B | $16.5B | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | $18.1B | ||
| Q2 24 | $6.8B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $595.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DXCM
GFS
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | — | ||
| Q3 25 | $659.9M | $595.0M | ||
| Q2 25 | $303.0M | $431.0M | ||
| Q1 25 | $183.8M | $331.0M | ||
| Q4 24 | $301.4M | — | ||
| Q3 24 | $199.5M | $375.0M | ||
| Q2 24 | $279.4M | $402.0M |
自由现金流
DXCM
GFS
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
自由现金流率
DXCM
GFS
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
资本支出强度
DXCM
GFS
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
现金转化率
DXCM
GFS
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 2.39× | ||
| Q2 25 | 1.69× | 1.89× | ||
| Q1 25 | 1.74× | 1.57× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 2.11× | ||
| Q2 24 | 1.95× | 2.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
GFS
| Smart Mobile Devices | $752.0M | 45% |
| Automotive | $306.0M | 18% |
| Home And Industrial Io T | $258.0M | 15% |
| Goods Or Services Transferred Over Time | $198.0M | 12% |
| Communications Infrastructure Datacenter | $175.0M | 10% |